文献速递慢性静脉疾病

VQI静脉曲张注册研究中不适宜主干静脉腔内消融治疗的发生频率

Frequency of inappropriate endovenous truncal ablation therapy within the vascular quality initiative varicose vein registry.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2026-03-25

基于VQI静脉曲张注册研究2015年1月至2022年9月共32,558例主干静脉腔内消融手术,90.1%完全符合指南适宜标准,仅1.8%和1.3%分别包含至少一项rarely appropriate或never appropriate治疗。既往静脉曲张干预史、非白人族裔、门诊手术室及双侧干预与never appropriate治疗相关,保险状态无关联;38%的不适宜手术集中于4个中心。

要点

  • 绝大多数主干静脉腔内消融符合适宜标准,不适宜治疗比例低。
  • 既往静脉曲张干预史、非白人族裔、门诊手术室及双侧干预与never appropriate治疗相关。
  • 保险状态与偏离指南治疗无关联,不适宜手术存在中心聚集现象。

核心结论

  • VQI-VVR注册分析显示不适宜EVA手术发生率低,仍需持续教育和质量改进以确保遵循循证指南。

研究设计与样本

  • 回顾性注册研究,纳入2015年1月至2022年9月参与VQI中心接受主干静脉EVA的患者,共分析32,558例手术。

主要发现

  • 全部治疗静脉均指南适宜的手术占90.1%,至少一项rarely appropriate和never appropriate分别占1.8%和1.3%。
  • 既往静脉曲张干预史(OR 2.4,95%CI 2.0-2.9,P<.0001)和非白人族裔(OR 2.1,95%CI 1.7-4.2,P<.0001)与接受never appropriate治疗相关。
  • 门诊手术室(OR 2.7,95%CI 1.9-4.0,P<.0001)和双侧干预(OR 1.9,95%CI 1.2-2.9,P=.003)与never appropriate治疗相关。
  • 治疗静脉数量增加与不适宜治疗正相关(3[IQR 1-2] vs 3[IQR 2-4],P<.0001;2[IQR 1-2] vs 2[IQR 2-4],P<.0001)。
  • 70%患者有私人保险,但保险状态与偏离指南治疗无关联;38%的不适宜手术发生在4个中心。

关键数值与推荐

  • 依据2020年美国静脉论坛/血管外科学会/美国静脉与淋巴学会/介入放射学会适宜使用标准判定适宜性。
  • 全部治疗静脉均指南适宜的手术占90.1%,至少一项rarely appropriate占1.8%,至少一项never appropriate占1.3%。

临床怎么用

  • 临床应遵循2020年多学会适宜使用标准选择主干静脉EVA,尤其关注既往干预史、双侧干预及门诊手术室等与不适宜治疗相关的因素。
  • 中心层面不适宜手术聚集提示需针对高发中心开展质量改进和教育。

局限性

  • 原文未报告

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Chronic venous disease is a pervasive problem, with a spectrum of severity and an equally diverse range of potential treatment settings and proceduralists. The adoption of endovenous ablation (EVA) techniques has facilitated the growth in office-based and ambulatory procedures. Concurrently, the impact of external factors including market compensation and insurance policies is known to influence procedural patterns away from evidence-based therapy. Using the Vascular Quality Initiative Varicose Vein Registry (VQI-VVR), we aimed to investigate trends in EVA therapies and ascertain trends in compliance with appropriate use criteria. We hypothesized that variation would exist in venous disease treatment patterns, and that treatment location and insurance status would influence the likelihood of nonconformity with these guidelines. METHODS: We identified patients undergoing truncal vein EVA procedures from participating VQI centers between January 2015 and September 2022. Procedures limited to perforator ablation, remnant or recanalized veins, or stab phlebectomy alone were excluded, as well as procedures performed on patients failing to meet the VQI-VVR inclusion criteria. The primary objective was to evaluate practice variation and identify factors associated with noncompliance with 2020 American Venous Forum/Society for Vascular Surgery/American Vein and Lymphatic Society/Society of Interventional Radiology appropriate use criteria. Secondary objectives compared outcomes between patients treated in accordance with vs outside of the guideline recommendations. RESULTS: A total of 32,558 procedures were analyzed and stratified into appropriateness subgroups. Procedures in which all treated veins were guideline appropriate interventions comprised 90.1% of the cohort. Interventions with at least one treatment designated as rarely appropriate or never appropriate guideline therapy comprised 1.8% and 1.3% of the cohort, respectively. Comparative analysis between appropriate and the inappropriate (ie, rarely appropriate, and never appropriate) treatment revealed prior varicose vein intervention (odds ratio [OR], 2.4; 95% confidence interval [CI], 2.0-2.9; P < .0001) and non-White race (OR, 2.1; 95% CI, 1.7-4.2; P < .0001) was associated with receiving a never appropriate treatment. Office-based settings (OR, 2.7; 95% CI, 1.9-4.0; P < .0001) and bilateral interventions (OR, 1.9; 95% CI, 1.2-2.9]; P = .003) were associated with never appropriate treatment. Increasing the number of veins treated was positively associated with inappropriate treatment (3 [interquartile range (IQR), 1-2] vs 3 [IQR, 2-4]; P < .0001 and 2 [IQR, 1-2] vs 2 [IQR, 2-4]; P < .0001). Most patients were privately insured (70%); however, there was no association between insurance status and off-guideline therapy. Center-level analysis revealed that 38% of all inappropriate procedures occurred at four centers. CONCLUSIONS: Analysis of the VQI-VVR registry demonstrates a low incidence of inappropriate EVA procedures. These findings underscore the importance of continued education and quality improvement efforts to ensure adherence to evidence-based guidelines for venous ablation.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Fassler MJ, Góngora A, Stinson G, et al. Frequency of inappropriate endovenous truncal ablation therapy within the vascular quality initiative varicose vein registry. J Vasc Surg Venous Lymphat Disord. 2026. PMID: 41895470. doi:10.1016/j.jvsv.2026.102493

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。